OrganiGram (CVE:OGI) has been given a C$9.00 price target by analysts at CIBC in a research note issued to investors on Tuesday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. CIBC’s price objective would suggest a potential upside of 44.69% from the company’s previous close.
Separately, AltaCorp Capital reissued an “outperform” rating on shares of OrganiGram in a research note on Sunday, June 2nd. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of C$10.42.
Shares of OGI stock remained flat at $C$6.22 during mid-day trading on Tuesday. The stock had a trading volume of 671,781 shares, compared to its average volume of 1,315,291. The business has a fifty day moving average price of C$6.59 and a two-hundred day moving average price of C$8.42. OrganiGram has a 12-month low of C$4.11 and a 12-month high of C$11.30. The stock has a market capitalization of $661.23 million and a P/E ratio of 28.02. The company has a debt-to-equity ratio of 14.71, a quick ratio of 4.14 and a current ratio of 9.06.
OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.
Featured Article: What is a death cross?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.